Arlene Morris
Director · Cogent Biosciences, Inc.
- 2025
- Aug 31, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Arlene Morris files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Fairmount Funds Management LLC - $370.02M in COGT purchases and sales in the last 12 months
- John Edward Robinson - $3.49M in COGT purchases and sales in the last 12 months
- Jessica Sachs - $3.20M in COGT purchases and sales in the last 12 months
- John L. Green - $2.98M in COGT purchases and sales in the last 12 months
- Evan Kearns - $2.52M in COGT purchases and sales in the last 12 months
- Stephen T. Wills - $9K in PTN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Arlene Morris?
Arlene Morris is a corporate insider, tracked as Director of Cogent Biosciences, Inc. (COGT). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Arlene Morris submitted recently?
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Arlene Morris been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($1.69M) across all tracked filings.